Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Daxas for COPD Therapy (DACOTA)

NCT01285167 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01285167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01285167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Daxas for COPD Therapy (DACOTA)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
August 31, 2010
Completion date
February 29, 2012
Enrollment
3,645 (actual)
Sites
605

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease